| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 51 | 2025 | 4881 | 4.690 |
Why?
|
| Population Surveillance | 40 | 2015 | 2594 | 4.160 |
Why?
|
| Medical Records Systems, Computerized | 28 | 2020 | 1196 | 4.150 |
Why?
|
| Computer Security | 23 | 2022 | 261 | 3.570 |
Why?
|
| Information Dissemination | 16 | 2024 | 1142 | 2.730 |
Why?
|
| Confidentiality | 22 | 2022 | 607 | 2.580 |
Why?
|
| Health Insurance Portability and Accountability Act | 6 | 2022 | 105 | 2.580 |
Why?
|
| Health Level Seven | 7 | 2024 | 35 | 2.480 |
Why?
|
| Patient Access to Records | 12 | 2016 | 120 | 2.400 |
Why?
|
| Public Health Informatics | 14 | 2012 | 109 | 2.310 |
Why?
|
| Software | 22 | 2024 | 4472 | 2.240 |
Why?
|
| Information Storage and Retrieval | 10 | 2019 | 833 | 2.120 |
Why?
|
| Disease Outbreaks | 26 | 2010 | 1761 | 2.090 |
Why?
|
| Pharyngitis | 7 | 2020 | 221 | 1.930 |
Why?
|
| Medical Record Linkage | 9 | 2015 | 286 | 1.810 |
Why?
|
| Bioterrorism | 12 | 2007 | 144 | 1.810 |
Why?
|
| Artificial Intelligence | 8 | 2025 | 2666 | 1.790 |
Why?
|
| Health Records, Personal | 8 | 2022 | 126 | 1.780 |
Why?
|
| Streptococcus pyogenes | 7 | 2020 | 293 | 1.770 |
Why?
|
| Medical Informatics | 10 | 2025 | 744 | 1.760 |
Why?
|
| Internet | 27 | 2016 | 3114 | 1.750 |
Why?
|
| Streptococcal Infections | 8 | 2020 | 618 | 1.690 |
Why?
|
| Computer Communication Networks | 7 | 2019 | 292 | 1.510 |
Why?
|
| Privacy | 9 | 2022 | 233 | 1.340 |
Why?
|
| Biosurveillance | 2 | 2024 | 16 | 1.300 |
Why?
|
| Insurance Claim Review | 3 | 2020 | 744 | 1.270 |
Why?
|
| Hypertension, Pulmonary | 7 | 2022 | 1604 | 1.240 |
Why?
|
| Lyme Disease | 4 | 2016 | 627 | 1.240 |
Why?
|
| Ecosystem | 2 | 2024 | 489 | 1.220 |
Why?
|
| Geographic Information Systems | 5 | 2008 | 283 | 1.150 |
Why?
|
| Insurance Claim Reporting | 4 | 2017 | 166 | 1.130 |
Why?
|
| General Practitioners | 3 | 2024 | 103 | 1.130 |
Why?
|
| Influenza, Human | 12 | 2011 | 1543 | 1.120 |
Why?
|
| Access to Information | 3 | 2022 | 317 | 1.070 |
Why?
|
| Emergency Service, Hospital | 28 | 2023 | 7871 | 1.050 |
Why?
|
| Computer Systems | 9 | 2007 | 468 | 0.960 |
Why?
|
| Clinical Trials as Topic | 11 | 2019 | 8048 | 0.910 |
Why?
|
| Primary Health Care | 8 | 2024 | 4746 | 0.900 |
Why?
|
| Humans | 261 | 2025 | 767040 | 0.900 |
Why?
|
| Inappropriate Prescribing | 2 | 2017 | 212 | 0.870 |
Why?
|
| United States | 68 | 2025 | 72971 | 0.850 |
Why?
|
| Genetic Privacy | 3 | 2012 | 59 | 0.850 |
Why?
|
| Decision Support Techniques | 10 | 2020 | 2006 | 0.830 |
Why?
|
| User-Computer Interface | 10 | 2019 | 1411 | 0.820 |
Why?
|
| Hospitals, Pediatric | 14 | 2016 | 1856 | 0.820 |
Why?
|
| Social Support | 4 | 2015 | 2192 | 0.810 |
Why?
|
| Patient Participation | 6 | 2014 | 1444 | 0.790 |
Why?
|
| Current Procedural Terminology | 2 | 2020 | 101 | 0.760 |
Why?
|
| Child | 80 | 2024 | 80771 | 0.760 |
Why?
|
| Medical Records | 8 | 2010 | 1409 | 0.760 |
Why?
|
| United States Federal Trade Commission | 1 | 2021 | 10 | 0.750 |
Why?
|
| Product Surveillance, Postmarketing | 3 | 2015 | 463 | 0.740 |
Why?
|
| Systems Integration | 11 | 2016 | 425 | 0.730 |
Why?
|
| Retrospective Studies | 60 | 2025 | 81659 | 0.730 |
Why?
|
| Cost of Illness | 5 | 2013 | 1951 | 0.710 |
Why?
|
| Social Participation | 2 | 2013 | 187 | 0.710 |
Why?
|
| Delivery of Health Care | 8 | 2025 | 5363 | 0.690 |
Why?
|
| Data Mining | 4 | 2017 | 561 | 0.680 |
Why?
|
| Biomedical Research | 12 | 2019 | 3464 | 0.660 |
Why?
|
| Algorithms | 16 | 2021 | 14098 | 0.660 |
Why?
|
| Models, Statistical | 11 | 2017 | 5098 | 0.650 |
Why?
|
| Registries | 14 | 2022 | 8351 | 0.630 |
Why?
|
| Pharmacogenetics | 2 | 2021 | 682 | 0.630 |
Why?
|
| Virus Diseases | 3 | 2023 | 722 | 0.630 |
Why?
|
| Vaccines | 3 | 2020 | 842 | 0.630 |
Why?
|
| Organizational Innovation | 2 | 2020 | 539 | 0.590 |
Why?
|
| Natural Language Processing | 5 | 2025 | 1202 | 0.590 |
Why?
|
| Point-of-Care Systems | 4 | 2016 | 1217 | 0.580 |
Why?
|
| Hospital Information Systems | 6 | 2011 | 395 | 0.580 |
Why?
|
| Genomics | 7 | 2022 | 5924 | 0.580 |
Why?
|
| Sentinel Surveillance | 4 | 2007 | 292 | 0.570 |
Why?
|
| Medical Informatics Applications | 4 | 2009 | 180 | 0.570 |
Why?
|
| Insurance, Health | 4 | 2020 | 2519 | 0.560 |
Why?
|
| Public Health | 9 | 2018 | 2681 | 0.560 |
Why?
|
| Cluster Analysis | 6 | 2008 | 2721 | 0.560 |
Why?
|
| Health Services Research | 4 | 2011 | 1815 | 0.560 |
Why?
|
| Databases, Factual | 8 | 2020 | 8068 | 0.550 |
Why?
|
| Mammography | 3 | 2017 | 2431 | 0.550 |
Why?
|
| Child, Preschool | 45 | 2024 | 42606 | 0.550 |
Why?
|
| Communication | 7 | 2024 | 3904 | 0.540 |
Why?
|
| Adolescent | 56 | 2024 | 89046 | 0.520 |
Why?
|
| Research Support as Topic | 5 | 2016 | 697 | 0.520 |
Why?
|
| Risk Assessment | 14 | 2020 | 24299 | 0.510 |
Why?
|
| Mass Screening | 4 | 2021 | 5456 | 0.510 |
Why?
|
| False Positive Reactions | 2 | 2016 | 959 | 0.510 |
Why?
|
| Mesalamine | 1 | 2016 | 133 | 0.510 |
Why?
|
| Anthrax | 3 | 2007 | 83 | 0.510 |
Why?
|
| Appendicitis | 5 | 2004 | 679 | 0.510 |
Why?
|
| Diagnostic Techniques and Procedures | 1 | 2017 | 216 | 0.510 |
Why?
|
| Databases as Topic | 1 | 2017 | 472 | 0.510 |
Why?
|
| Respiratory Tract Infections | 4 | 2008 | 1009 | 0.500 |
Why?
|
| Biological Factors | 1 | 2016 | 155 | 0.500 |
Why?
|
| Tick-Borne Diseases | 1 | 2015 | 37 | 0.490 |
Why?
|
| Hospitalization | 10 | 2021 | 10815 | 0.490 |
Why?
|
| Language | 2 | 2025 | 1550 | 0.490 |
Why?
|
| Health Expenditures | 4 | 2017 | 2390 | 0.480 |
Why?
|
| Early Detection of Cancer | 4 | 2017 | 3236 | 0.480 |
Why?
|
| Infant | 37 | 2022 | 36485 | 0.470 |
Why?
|
| Pediatrics | 10 | 2019 | 3621 | 0.470 |
Why?
|
| Software Design | 3 | 2012 | 173 | 0.470 |
Why?
|
| Patient Compliance | 3 | 2024 | 2697 | 0.460 |
Why?
|
| Diagnostic Tests, Routine | 2 | 2019 | 788 | 0.460 |
Why?
|
| Computer Simulation | 5 | 2021 | 6260 | 0.450 |
Why?
|
| Anti-Bacterial Agents | 5 | 2016 | 7469 | 0.450 |
Why?
|
| Epidemics | 1 | 2020 | 516 | 0.450 |
Why?
|
| Female | 88 | 2025 | 396660 | 0.450 |
Why?
|
| Male | 81 | 2025 | 364203 | 0.440 |
Why?
|
| Clinical Laboratory Information Systems | 2 | 2012 | 108 | 0.430 |
Why?
|
| Diabetes Mellitus | 4 | 2013 | 5886 | 0.420 |
Why?
|
| Medical History Taking | 5 | 2009 | 779 | 0.410 |
Why?
|
| Databases, Genetic | 5 | 2021 | 1758 | 0.410 |
Why?
|
| Computing Methodologies | 1 | 2012 | 17 | 0.410 |
Why?
|
| DNA Fingerprinting | 1 | 2012 | 114 | 0.410 |
Why?
|
| Massachusetts | 17 | 2011 | 8890 | 0.400 |
Why?
|
| Information Systems | 2 | 2012 | 400 | 0.400 |
Why?
|
| Disclosure | 2 | 2012 | 755 | 0.400 |
Why?
|
| Drug Interactions | 1 | 2017 | 1419 | 0.400 |
Why?
|
| Insulin Infusion Systems | 1 | 2013 | 221 | 0.390 |
Why?
|
| Online Systems | 1 | 2013 | 181 | 0.390 |
Why?
|
| Epilepsy | 3 | 2022 | 3317 | 0.390 |
Why?
|
| Informatics | 1 | 2012 | 72 | 0.390 |
Why?
|
| Patient Selection | 4 | 2017 | 4256 | 0.390 |
Why?
|
| Health Knowledge, Attitudes, Practice | 5 | 2012 | 4054 | 0.380 |
Why?
|
| Databases, Nucleic Acid | 1 | 2012 | 203 | 0.380 |
Why?
|
| Models, Organizational | 1 | 2015 | 548 | 0.380 |
Why?
|
| Boston | 15 | 2016 | 9360 | 0.380 |
Why?
|
| Empirical Research | 1 | 2012 | 119 | 0.380 |
Why?
|
| Bayes Theorem | 3 | 2020 | 2353 | 0.380 |
Why?
|
| Adult | 47 | 2025 | 223317 | 0.380 |
Why?
|
| Fever | 4 | 2012 | 1605 | 0.370 |
Why?
|
| Parents | 10 | 2016 | 3594 | 0.370 |
Why?
|
| Cooperative Behavior | 2 | 2017 | 1512 | 0.360 |
Why?
|
| Rhabdomyolysis | 1 | 2012 | 150 | 0.360 |
Why?
|
| Developed Countries | 1 | 2013 | 453 | 0.360 |
Why?
|
| Sensitivity and Specificity | 18 | 2021 | 14672 | 0.350 |
Why?
|
| Hospital Communication Systems | 2 | 2017 | 47 | 0.350 |
Why?
|
| Security Measures | 2 | 2008 | 83 | 0.350 |
Why?
|
| Drugs, Investigational | 1 | 2012 | 211 | 0.350 |
Why?
|
| Blood Glucose Self-Monitoring | 1 | 2013 | 475 | 0.350 |
Why?
|
| Infant, Newborn | 27 | 2022 | 26396 | 0.350 |
Why?
|
| Secondary Prevention | 1 | 2016 | 1472 | 0.340 |
Why?
|
| Chronic Disease | 4 | 2013 | 9362 | 0.340 |
Why?
|
| Purpura | 2 | 2003 | 117 | 0.340 |
Why?
|
| Epilepsy, Rolandic | 2 | 2021 | 57 | 0.340 |
Why?
|
| Maps as Topic | 2 | 2006 | 18 | 0.340 |
Why?
|
| Hypoglycemic Agents | 3 | 2019 | 3108 | 0.340 |
Why?
|
| Education, Medical | 1 | 2022 | 1746 | 0.340 |
Why?
|
| Models, Theoretical | 4 | 2012 | 3561 | 0.340 |
Why?
|
| Middle Aged | 36 | 2025 | 223233 | 0.330 |
Why?
|
| Publication Bias | 1 | 2010 | 158 | 0.330 |
Why?
|
| Comparative Effectiveness Research | 2 | 2012 | 713 | 0.330 |
Why?
|
| Respiratory Sounds | 1 | 2014 | 702 | 0.330 |
Why?
|
| Hemorrhagic Fever, Ebola | 1 | 2014 | 424 | 0.330 |
Why?
|
| Ambulatory Care | 3 | 2017 | 2780 | 0.330 |
Why?
|
| Drug Utilization | 1 | 2015 | 1190 | 0.330 |
Why?
|
| Information Services | 3 | 2008 | 239 | 0.320 |
Why?
|
| Whooping Cough | 1 | 2010 | 87 | 0.320 |
Why?
|
| Benzodiazepines | 1 | 2015 | 1137 | 0.320 |
Why?
|
| Epidemiologic Measurements | 3 | 2005 | 23 | 0.320 |
Why?
|
| Drug Evaluation | 1 | 2010 | 641 | 0.320 |
Why?
|
| Hospital Costs | 4 | 2017 | 956 | 0.310 |
Why?
|
| Drug Monitoring | 2 | 2012 | 963 | 0.310 |
Why?
|
| Accidental Falls | 1 | 2017 | 1079 | 0.310 |
Why?
|
| Data Collection | 6 | 2021 | 3321 | 0.310 |
Why?
|
| Practice Guidelines as Topic | 7 | 2016 | 7435 | 0.310 |
Why?
|
| Adolescent Health Services | 1 | 2011 | 220 | 0.310 |
Why?
|
| Pharmacoepidemiology | 1 | 2012 | 351 | 0.310 |
Why?
|
| American Recovery and Reinvestment Act | 2 | 2020 | 72 | 0.310 |
Why?
|
| Genome, Human | 2 | 2019 | 4441 | 0.310 |
Why?
|
| Students, Medical | 1 | 2022 | 1965 | 0.310 |
Why?
|
| Adverse Drug Reaction Reporting Systems | 1 | 2012 | 497 | 0.300 |
Why?
|
| Reimbursement, Incentive | 1 | 2013 | 541 | 0.300 |
Why?
|
| Medicare Part C | 1 | 2013 | 333 | 0.300 |
Why?
|
| Research Design | 6 | 2017 | 6210 | 0.300 |
Why?
|
| Social Adjustment | 1 | 2011 | 634 | 0.300 |
Why?
|
| Publishing | 2 | 2021 | 837 | 0.300 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2013 | 3249 | 0.290 |
Why?
|
| Drug Approval | 2 | 2014 | 820 | 0.290 |
Why?
|
| Domestic Violence | 1 | 2009 | 180 | 0.290 |
Why?
|
| Cohort Studies | 20 | 2023 | 41718 | 0.290 |
Why?
|
| Polypharmacy | 1 | 2010 | 307 | 0.290 |
Why?
|
| Respiratory Syncytial Virus Infections | 2 | 2009 | 366 | 0.280 |
Why?
|
| Patient-Centered Care | 2 | 2016 | 1444 | 0.280 |
Why?
|
| Prostate-Specific Antigen | 1 | 2017 | 2463 | 0.280 |
Why?
|
| Respiratory Syncytial Virus, Human | 1 | 2009 | 150 | 0.280 |
Why?
|
| West Nile Fever | 1 | 2007 | 77 | 0.270 |
Why?
|
| Young Adult | 20 | 2021 | 59980 | 0.270 |
Why?
|
| Autoimmune Diseases | 2 | 2021 | 2255 | 0.270 |
Why?
|
| Community Networks | 1 | 2008 | 202 | 0.270 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2012 | 746 | 0.270 |
Why?
|
| Commerce | 1 | 2012 | 614 | 0.270 |
Why?
|
| Drug Prescriptions | 2 | 2015 | 1664 | 0.270 |
Why?
|
| Meningitis, Aseptic | 1 | 2007 | 59 | 0.270 |
Why?
|
| Suicide | 3 | 2023 | 1606 | 0.270 |
Why?
|
| Facial Paralysis | 1 | 2011 | 346 | 0.270 |
Why?
|
| Communicable Diseases, Emerging | 1 | 2008 | 149 | 0.270 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2016 | 2270 | 0.270 |
Why?
|
| Physicians | 2 | 2024 | 4593 | 0.270 |
Why?
|
| Age Factors | 9 | 2017 | 18401 | 0.270 |
Why?
|
| Epidemiologic Methods | 2 | 2008 | 1326 | 0.270 |
Why?
|
| Patient Care Team | 2 | 2015 | 2516 | 0.270 |
Why?
|
| Brain Waves | 2 | 2021 | 416 | 0.260 |
Why?
|
| Arthroplasty, Replacement, Hip | 1 | 2017 | 1417 | 0.260 |
Why?
|
| Syndrome | 4 | 2006 | 3271 | 0.260 |
Why?
|
| Arthroplasty, Replacement, Knee | 1 | 2017 | 1389 | 0.260 |
Why?
|
| Safety | 1 | 2011 | 1157 | 0.260 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 1168 | 0.250 |
Why?
|
| Regional Medical Programs | 1 | 2006 | 64 | 0.250 |
Why?
|
| Government Regulation | 3 | 2017 | 525 | 0.250 |
Why?
|
| Cyclooxygenase Inhibitors | 1 | 2007 | 361 | 0.250 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3112 | 0.250 |
Why?
|
| Hypoglycemia | 1 | 2013 | 896 | 0.250 |
Why?
|
| Anticonvulsants | 1 | 2015 | 1921 | 0.250 |
Why?
|
| Mandatory Reporting | 1 | 2006 | 123 | 0.250 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3234 | 0.250 |
Why?
|
| Aircraft | 1 | 2006 | 135 | 0.250 |
Why?
|
| Disease | 2 | 2008 | 675 | 0.250 |
Why?
|
| Patient Care | 2 | 2024 | 628 | 0.250 |
Why?
|
| Foreign Bodies | 2 | 2000 | 403 | 0.250 |
Why?
|
| Time Factors | 13 | 2021 | 40154 | 0.240 |
Why?
|
| Lactones | 1 | 2007 | 315 | 0.240 |
Why?
|
| Codes of Ethics | 1 | 2025 | 61 | 0.240 |
Why?
|
| Sulfones | 1 | 2007 | 447 | 0.240 |
Why?
|
| Health Care Costs | 2 | 2017 | 3239 | 0.240 |
Why?
|
| Meningitis, Bacterial | 1 | 2007 | 222 | 0.230 |
Why?
|
| Attitude of Health Personnel | 3 | 2018 | 3928 | 0.230 |
Why?
|
| Developing Countries | 2 | 2015 | 2911 | 0.230 |
Why?
|
| Baseball | 1 | 2005 | 95 | 0.230 |
Why?
|
| Drug Industry | 4 | 2016 | 791 | 0.230 |
Why?
|
| Breast Neoplasms | 3 | 2017 | 21178 | 0.230 |
Why?
|
| Spinal Puncture | 1 | 2006 | 284 | 0.230 |
Why?
|
| Odds Ratio | 6 | 2021 | 9660 | 0.230 |
Why?
|
| Research Subjects | 2 | 2017 | 249 | 0.220 |
Why?
|
| Mass Vaccination | 1 | 2005 | 111 | 0.220 |
Why?
|
| Multivariate Analysis | 8 | 2016 | 12069 | 0.220 |
Why?
|
| Health Services | 2 | 2000 | 755 | 0.220 |
Why?
|
| Crohn Disease | 1 | 2016 | 2295 | 0.220 |
Why?
|
| Regression Analysis | 7 | 2020 | 6331 | 0.220 |
Why?
|
| Postnatal Care | 4 | 2004 | 273 | 0.220 |
Why?
|
| Patient Transfer | 1 | 2011 | 788 | 0.220 |
Why?
|
| Esophagus | 2 | 2000 | 1041 | 0.220 |
Why?
|
| Continuity of Patient Care | 1 | 2011 | 1078 | 0.220 |
Why?
|
| Interdisciplinary Communication | 2 | 2008 | 935 | 0.220 |
Why?
|
| Patient Readmission | 2 | 2017 | 3283 | 0.210 |
Why?
|
| Thermometers | 1 | 2023 | 42 | 0.210 |
Why?
|
| APACHE | 1 | 2024 | 268 | 0.210 |
Why?
|
| Immunization | 1 | 2007 | 1218 | 0.210 |
Why?
|
| Decision Support Systems, Clinical | 3 | 2016 | 1178 | 0.210 |
Why?
|
| Incidence | 9 | 2015 | 21526 | 0.210 |
Why?
|
| Partial Thromboplastin Time | 1 | 2003 | 203 | 0.200 |
Why?
|
| Public Health Administration | 2 | 2005 | 242 | 0.200 |
Why?
|
| International Classification of Diseases | 3 | 2009 | 935 | 0.200 |
Why?
|
| Influenza Vaccines | 2 | 2011 | 780 | 0.200 |
Why?
|
| Logistic Models | 8 | 2012 | 13284 | 0.200 |
Why?
|
| Attitude to Computers | 2 | 2000 | 196 | 0.200 |
Why?
|
| Patients | 2 | 2000 | 908 | 0.200 |
Why?
|
| Quality Indicators, Health Care | 1 | 2012 | 1804 | 0.200 |
Why?
|
| Aged | 21 | 2025 | 171319 | 0.200 |
Why?
|
| Ciprofloxacin | 1 | 2004 | 313 | 0.200 |
Why?
|
| Forecasting | 3 | 2020 | 2936 | 0.190 |
Why?
|
| Reproducibility of Results | 11 | 2021 | 20169 | 0.190 |
Why?
|
| Opsoclonus-Myoclonus Syndrome | 1 | 2021 | 9 | 0.190 |
Why?
|
| Ireland | 1 | 2022 | 171 | 0.190 |
Why?
|
| Medication Adherence | 1 | 2013 | 2191 | 0.190 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2014 | 3724 | 0.190 |
Why?
|
| Dehydration | 1 | 2003 | 216 | 0.190 |
Why?
|
| Asthma | 3 | 2024 | 6268 | 0.190 |
Why?
|
| Phenotype | 6 | 2021 | 16718 | 0.180 |
Why?
|
| Length of Stay | 5 | 2004 | 6489 | 0.180 |
Why?
|
| Health Policy | 3 | 2009 | 2698 | 0.180 |
Why?
|
| Geography | 4 | 2008 | 651 | 0.180 |
Why?
|
| Entropy | 1 | 2021 | 210 | 0.180 |
Why?
|
| Pandemics | 6 | 2023 | 8736 | 0.180 |
Why?
|
| Seasons | 4 | 2007 | 1523 | 0.180 |
Why?
|
| Travel | 1 | 2006 | 805 | 0.170 |
Why?
|
| Consumer Product Safety | 1 | 2021 | 122 | 0.170 |
Why?
|
| Glutamine | 1 | 2023 | 575 | 0.170 |
Why?
|
| Telemedicine | 2 | 2016 | 3110 | 0.170 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2017 | 10393 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 3 | 2021 | 12250 | 0.170 |
Why?
|
| Prevalence | 7 | 2021 | 15851 | 0.170 |
Why?
|
| Physician-Patient Relations | 4 | 2012 | 3266 | 0.170 |
Why?
|
| Interprofessional Relations | 2 | 2017 | 1000 | 0.170 |
Why?
|
| Cross-Sectional Studies | 8 | 2018 | 26325 | 0.170 |
Why?
|
| Papillomavirus Vaccines | 2 | 2017 | 497 | 0.170 |
Why?
|
| Office Visits | 2 | 2014 | 595 | 0.170 |
Why?
|
| Humidity | 1 | 2020 | 207 | 0.160 |
Why?
|
| Ethics Committees, Research | 2 | 2019 | 196 | 0.160 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2017 | 3232 | 0.160 |
Why?
|
| Empathy | 1 | 2024 | 474 | 0.160 |
Why?
|
| Urine | 1 | 2000 | 362 | 0.160 |
Why?
|
| Infection Control | 1 | 2006 | 984 | 0.160 |
Why?
|
| Molecular Sequence Annotation | 2 | 2019 | 526 | 0.160 |
Why?
|
| Predictive Value of Tests | 8 | 2017 | 15424 | 0.160 |
Why?
|
| Quality of Health Care | 2 | 2011 | 4306 | 0.160 |
Why?
|
| Antibiotic Prophylaxis | 1 | 2004 | 640 | 0.160 |
Why?
|
| Genetic Research | 2 | 2012 | 173 | 0.160 |
Why?
|
| Benchmarking | 1 | 2005 | 1056 | 0.150 |
Why?
|
| Respiratory Tract Diseases | 1 | 2004 | 744 | 0.150 |
Why?
|
| Fragile X Syndrome | 1 | 2020 | 116 | 0.150 |
Why?
|
| Computational Biology | 2 | 2021 | 3567 | 0.150 |
Why?
|
| Education | 1 | 2021 | 531 | 0.150 |
Why?
|
| Drug Labeling | 1 | 2021 | 251 | 0.150 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2013 | 3449 | 0.150 |
Why?
|
| Personal Autonomy | 2 | 2012 | 316 | 0.150 |
Why?
|
| Seizures | 2 | 2022 | 2996 | 0.150 |
Why?
|
| Blood | 1 | 2000 | 596 | 0.150 |
Why?
|
| Diagnostic Imaging | 1 | 2012 | 3530 | 0.150 |
Why?
|
| Nervous System Diseases | 3 | 2016 | 1660 | 0.150 |
Why?
|
| Peer Review | 1 | 2020 | 218 | 0.150 |
Why?
|
| Age Distribution | 5 | 2011 | 2870 | 0.150 |
Why?
|
| Cerebrospinal Fluid | 1 | 2000 | 540 | 0.150 |
Why?
|
| Sulfonamides | 1 | 2007 | 1982 | 0.140 |
Why?
|
| Mass Media | 3 | 2009 | 303 | 0.140 |
Why?
|
| Infant Welfare | 1 | 1997 | 79 | 0.140 |
Why?
|
| Hypolipidemic Agents | 2 | 2012 | 609 | 0.140 |
Why?
|
| Meningococcal Infections | 1 | 1997 | 78 | 0.140 |
Why?
|
| Documentation | 1 | 2024 | 915 | 0.140 |
Why?
|
| Neisseria meningitidis | 1 | 1997 | 111 | 0.140 |
Why?
|
| Sleep Stages | 1 | 2021 | 705 | 0.140 |
Why?
|
| Neonatal Screening | 1 | 2002 | 620 | 0.140 |
Why?
|
| INDEL Mutation | 1 | 2018 | 266 | 0.140 |
Why?
|
| Selection Bias | 1 | 2019 | 360 | 0.140 |
Why?
|
| Models, Biological | 4 | 2011 | 9464 | 0.140 |
Why?
|
| Maternal Welfare | 1 | 1997 | 113 | 0.140 |
Why?
|
| Classification | 1 | 2017 | 128 | 0.140 |
Why?
|
| Pyrazoles | 1 | 2007 | 2028 | 0.140 |
Why?
|
| History, 21st Century | 2 | 2020 | 1574 | 0.140 |
Why?
|
| Electroencephalography | 3 | 2022 | 6282 | 0.140 |
Why?
|
| Quality Improvement | 1 | 2012 | 3854 | 0.140 |
Why?
|
| United States Food and Drug Administration | 3 | 2014 | 1672 | 0.130 |
Why?
|
| Normal Distribution | 2 | 2008 | 267 | 0.130 |
Why?
|
| Prescription Drugs | 2 | 2017 | 635 | 0.130 |
Why?
|
| Anti-Infective Agents | 1 | 2004 | 986 | 0.130 |
Why?
|
| Educational Status | 4 | 2010 | 2511 | 0.130 |
Why?
|
| Bacterial Infections | 2 | 2003 | 1390 | 0.130 |
Why?
|
| Guideline Adherence | 1 | 2006 | 2232 | 0.130 |
Why?
|
| Financing, Government | 2 | 2010 | 473 | 0.130 |
Why?
|
| Neuraminidase | 1 | 2016 | 192 | 0.130 |
Why?
|
| American Cancer Society | 1 | 2016 | 69 | 0.130 |
Why?
|
| Health Promotion | 1 | 2008 | 2210 | 0.130 |
Why?
|
| Communicable Diseases | 3 | 2009 | 872 | 0.120 |
Why?
|
| ROC Curve | 3 | 2021 | 3618 | 0.120 |
Why?
|
| Programming Languages | 1 | 2015 | 133 | 0.120 |
Why?
|
| Bacteremia | 2 | 2003 | 983 | 0.120 |
Why?
|
| Emergency Medical Services | 2 | 2005 | 1936 | 0.120 |
Why?
|
| Fourier Analysis | 2 | 2006 | 435 | 0.120 |
Why?
|
| Health Resources | 2 | 2013 | 948 | 0.120 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2024 | 1883 | 0.120 |
Why?
|
| Semantics | 1 | 2019 | 609 | 0.120 |
Why?
|
| Gastroesophageal Reflux | 1 | 2022 | 834 | 0.120 |
Why?
|
| Cost Savings | 2 | 2016 | 904 | 0.120 |
Why?
|
| Drug Therapy, Computer-Assisted | 1 | 2016 | 198 | 0.120 |
Why?
|
| Research Personnel | 1 | 2019 | 589 | 0.120 |
Why?
|
| Depression, Postpartum | 1 | 1999 | 355 | 0.120 |
Why?
|
| Copyright | 1 | 2014 | 13 | 0.120 |
Why?
|
| Review Literature as Topic | 1 | 2016 | 297 | 0.120 |
Why?
|
| Ultrasonography | 4 | 2004 | 6000 | 0.120 |
Why?
|
| Prostatic Neoplasms | 2 | 2017 | 11097 | 0.120 |
Why?
|
| Risk Factors | 10 | 2017 | 74886 | 0.120 |
Why?
|
| Diagnostic Self Evaluation | 1 | 2016 | 228 | 0.110 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15925 | 0.110 |
Why?
|
| Data Interpretation, Statistical | 2 | 2009 | 2698 | 0.110 |
Why?
|
| Ileum | 1 | 2016 | 558 | 0.110 |
Why?
|
| Embryonic Development | 1 | 2019 | 722 | 0.110 |
Why?
|
| Down Syndrome | 1 | 2022 | 916 | 0.110 |
Why?
|
| Child Health Services | 1 | 1999 | 645 | 0.110 |
Why?
|
| Biological Specimen Banks | 1 | 2019 | 787 | 0.110 |
Why?
|
| Connective Tissue Diseases | 1 | 2016 | 285 | 0.110 |
Why?
|
| Life Tables | 1 | 2013 | 367 | 0.110 |
Why?
|
| PubMed | 1 | 2014 | 129 | 0.110 |
Why?
|
| Pharmacies | 1 | 2015 | 171 | 0.110 |
Why?
|
| Vulnerable Populations | 1 | 2019 | 718 | 0.110 |
Why?
|
| Siblings | 1 | 2017 | 828 | 0.110 |
Why?
|
| Hepatitis C, Chronic | 1 | 2021 | 1032 | 0.110 |
Why?
|
| Blood Pressure Determination | 1 | 2017 | 646 | 0.110 |
Why?
|
| Metabolomics | 1 | 2022 | 1675 | 0.110 |
Why?
|
| Medical Staff, Hospital | 1 | 2017 | 602 | 0.110 |
Why?
|
| Homozygote | 1 | 2018 | 1774 | 0.110 |
Why?
|
| Organizations | 1 | 2014 | 172 | 0.110 |
Why?
|
| Authorship | 1 | 2016 | 289 | 0.110 |
Why?
|
| Neuropsychiatry | 1 | 2013 | 76 | 0.100 |
Why?
|
| Heart Failure | 1 | 2017 | 11877 | 0.100 |
Why?
|
| Computer-Assisted Instruction | 2 | 2008 | 368 | 0.100 |
Why?
|
| Equipment Safety | 1 | 2013 | 250 | 0.100 |
Why?
|
| Early Diagnosis | 2 | 2009 | 1188 | 0.100 |
Why?
|
| Vaccination | 2 | 2020 | 3434 | 0.100 |
Why?
|
| Back Pain | 1 | 2016 | 547 | 0.100 |
Why?
|
| Joint Diseases | 1 | 2016 | 461 | 0.100 |
Why?
|
| Pneumococcal Infections | 1 | 1997 | 529 | 0.100 |
Why?
|
| Poisoning | 1 | 1994 | 253 | 0.100 |
Why?
|
| Patient Discharge | 4 | 2003 | 3467 | 0.100 |
Why?
|
| Prospective Studies | 14 | 2019 | 54886 | 0.100 |
Why?
|
| Decision Trees | 2 | 2007 | 508 | 0.100 |
Why?
|
| Marketing | 1 | 2014 | 225 | 0.100 |
Why?
|
| Gestational Age | 1 | 2021 | 3618 | 0.100 |
Why?
|
| Sickness Impact Profile | 1 | 2013 | 299 | 0.100 |
Why?
|
| Comorbidity | 3 | 2020 | 10582 | 0.100 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2021 | 3667 | 0.100 |
Why?
|
| Postoperative Period | 1 | 2016 | 1824 | 0.090 |
Why?
|
| Serum Amyloid A Protein | 1 | 1991 | 128 | 0.090 |
Why?
|
| Conflict of Interest | 1 | 2016 | 556 | 0.090 |
Why?
|
| Jaundice, Neonatal | 2 | 2004 | 70 | 0.090 |
Why?
|
| Public Opinion | 1 | 2015 | 484 | 0.090 |
Why?
|
| Colectomy | 1 | 2016 | 696 | 0.090 |
Why?
|
| Choice Behavior | 1 | 2017 | 848 | 0.090 |
Why?
|
| Equipment Failure | 1 | 2013 | 585 | 0.090 |
Why?
|
| Heterozygote | 1 | 2018 | 2794 | 0.090 |
Why?
|
| Hepatitis C | 1 | 2021 | 1594 | 0.090 |
Why?
|
| Rare Diseases | 1 | 2016 | 630 | 0.090 |
Why?
|
| Disaster Planning | 3 | 2005 | 557 | 0.090 |
Why?
|
| Sample Size | 1 | 2014 | 845 | 0.090 |
Why?
|
| Eligibility Determination | 1 | 2014 | 421 | 0.090 |
Why?
|
| Income | 3 | 2015 | 1877 | 0.090 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2004 | 20741 | 0.090 |
Why?
|
| Insulin | 2 | 2017 | 6602 | 0.090 |
Why?
|
| National Library of Medicine (U.S.) | 1 | 2010 | 34 | 0.090 |
Why?
|
| Drug Therapy | 1 | 2013 | 504 | 0.090 |
Why?
|
| Longitudinal Studies | 3 | 2021 | 14766 | 0.090 |
Why?
|
| Ethics, Research | 1 | 2012 | 178 | 0.090 |
Why?
|
| Gene Regulatory Networks | 1 | 2019 | 1752 | 0.090 |
Why?
|
| Tracheotomy | 1 | 2011 | 174 | 0.090 |
Why?
|
| Health Maintenance Organizations | 2 | 2003 | 656 | 0.090 |
Why?
|
| Hospitals | 2 | 2017 | 3883 | 0.080 |
Why?
|
| Analysis of Variance | 2 | 2011 | 6215 | 0.080 |
Why?
|
| Metformin | 1 | 2017 | 908 | 0.080 |
Why?
|
| Acute Disease | 2 | 2012 | 7236 | 0.080 |
Why?
|
| Fatigue | 1 | 2016 | 1556 | 0.080 |
Why?
|
| Sweden | 1 | 2012 | 1382 | 0.080 |
Why?
|
| Environment | 2 | 2020 | 1120 | 0.080 |
Why?
|
| Equipment and Supplies | 1 | 2012 | 272 | 0.080 |
Why?
|
| Patient Identification Systems | 2 | 2007 | 75 | 0.080 |
Why?
|
| Telephone | 2 | 2003 | 629 | 0.080 |
Why?
|
| Technology, Pharmaceutical | 1 | 2009 | 83 | 0.080 |
Why?
|
| Financing, Organized | 1 | 2010 | 202 | 0.080 |
Why?
|
| Editorial Policies | 2 | 2010 | 458 | 0.080 |
Why?
|
| Mothers | 1 | 1999 | 2209 | 0.080 |
Why?
|
| Colon | 1 | 2016 | 1797 | 0.080 |
Why?
|
| Altruism | 1 | 2010 | 211 | 0.080 |
Why?
|
| Consumer Health Information | 1 | 2011 | 215 | 0.080 |
Why?
|
| Radio | 1 | 2007 | 9 | 0.080 |
Why?
|
| New York | 2 | 2008 | 879 | 0.080 |
Why?
|
| Utilization Review | 1 | 2009 | 381 | 0.070 |
Why?
|
| Follow-Up Studies | 5 | 2017 | 39317 | 0.070 |
Why?
|
| Confidence Intervals | 2 | 2011 | 2920 | 0.070 |
Why?
|
| Area Under Curve | 1 | 2012 | 1639 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2021 | 65295 | 0.070 |
Why?
|
| Medical Audit | 1 | 2009 | 454 | 0.070 |
Why?
|
| Genetic Counseling | 1 | 2012 | 635 | 0.070 |
Why?
|
| Electronics, Medical | 1 | 2007 | 70 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2016 | 2765 | 0.070 |
Why?
|
| Single-Cell Analysis | 1 | 2019 | 2538 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2024 | 7868 | 0.070 |
Why?
|
| Family Characteristics | 1 | 2012 | 1002 | 0.070 |
Why?
|
| New England | 1 | 2010 | 1058 | 0.070 |
Why?
|
| Occupational Health Services | 1 | 2008 | 149 | 0.070 |
Why?
|
| Health Status Indicators | 1 | 2012 | 969 | 0.070 |
Why?
|
| Poisson Distribution | 1 | 2008 | 507 | 0.070 |
Why?
|
| Linear Models | 3 | 2013 | 5875 | 0.070 |
Why?
|
| Russia | 1 | 2007 | 383 | 0.070 |
Why?
|
| Myocardial Infarction | 1 | 2007 | 11513 | 0.070 |
Why?
|
| Lung Diseases | 1 | 2016 | 1942 | 0.070 |
Why?
|
| Medical Order Entry Systems | 1 | 2011 | 523 | 0.070 |
Why?
|
| Postal Service | 1 | 2006 | 96 | 0.070 |
Why?
|
| Attitude to Health | 1 | 2015 | 2023 | 0.070 |
Why?
|
| Myocardial Ischemia | 1 | 2017 | 2131 | 0.070 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2014 | 951 | 0.070 |
Why?
|
| Database Management Systems | 1 | 2007 | 263 | 0.060 |
Why?
|
| Physical Examination | 2 | 2003 | 1265 | 0.060 |
Why?
|
| Health Personnel | 1 | 2020 | 3387 | 0.060 |
Why?
|
| Virus Cultivation | 1 | 2006 | 88 | 0.060 |
Why?
|
| Organizational Policy | 1 | 2008 | 435 | 0.060 |
Why?
|
| Enzyme Inhibitors | 1 | 2016 | 3726 | 0.060 |
Why?
|
| Patient Education as Topic | 2 | 2008 | 2337 | 0.060 |
Why?
|
| State Government | 1 | 2008 | 388 | 0.060 |
Why?
|
| Heart Defects, Congenital | 1 | 2022 | 4713 | 0.060 |
Why?
|
| Censuses | 1 | 2006 | 198 | 0.060 |
Why?
|
| Outpatients | 2 | 2010 | 1600 | 0.060 |
Why?
|
| Time | 1 | 2007 | 551 | 0.060 |
Why?
|
| Diagnosis, Differential | 3 | 2007 | 12986 | 0.060 |
Why?
|
| Feedback | 1 | 2009 | 797 | 0.060 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2006 | 117 | 0.060 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 1639 | 0.060 |
Why?
|
| Emergencies | 2 | 2003 | 1223 | 0.060 |
Why?
|
| Leukocytosis | 1 | 2006 | 248 | 0.060 |
Why?
|
| Hospital Charges | 2 | 2013 | 345 | 0.060 |
Why?
|
| Awareness | 1 | 2009 | 653 | 0.060 |
Why?
|
| Markov Chains | 1 | 2008 | 976 | 0.060 |
Why?
|
| Perception | 1 | 2011 | 1205 | 0.060 |
Why?
|
| Forms and Records Control | 2 | 2005 | 158 | 0.060 |
Why?
|
| Genetic Testing | 1 | 2017 | 3591 | 0.060 |
Why?
|
| Singapore | 1 | 2025 | 300 | 0.060 |
Why?
|
| Recurrence | 1 | 2016 | 8504 | 0.060 |
Why?
|
| Focus Groups | 1 | 2010 | 1460 | 0.060 |
Why?
|
| National Health Programs | 1 | 2007 | 443 | 0.050 |
Why?
|
| Pharmaceutical Preparations | 1 | 2012 | 1085 | 0.050 |
Why?
|
| Prothrombin Time | 1 | 2003 | 117 | 0.050 |
Why?
|
| Obstetrics and Gynecology Department, Hospital | 1 | 2003 | 41 | 0.050 |
Why?
|
| Appendix | 1 | 2004 | 110 | 0.050 |
Why?
|
| Mental Disorders | 2 | 2020 | 6873 | 0.050 |
Why?
|
| Television | 1 | 2005 | 409 | 0.050 |
Why?
|
| Italy | 1 | 2025 | 856 | 0.050 |
Why?
|
| Immunization Programs | 1 | 2005 | 267 | 0.050 |
Why?
|
| Learning | 1 | 2012 | 1754 | 0.050 |
Why?
|
| Trauma Severity Indices | 1 | 2004 | 479 | 0.050 |
Why?
|
| Intellectual Property | 1 | 2022 | 32 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 1 | 2004 | 1623 | 0.050 |
Why?
|
| Mandatory Testing | 1 | 2002 | 23 | 0.050 |
Why?
|
| Bacteriological Techniques | 1 | 2003 | 277 | 0.050 |
Why?
|
| Viruses | 1 | 2006 | 371 | 0.050 |
Why?
|
| Antihypertensive Agents | 1 | 2011 | 2030 | 0.050 |
Why?
|
| Third-Party Consent | 1 | 2002 | 66 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2008 | 3431 | 0.050 |
Why?
|
| Genetic Variation | 2 | 2019 | 6611 | 0.050 |
Why?
|
| Electronic Mail | 1 | 2003 | 215 | 0.050 |
Why?
|
| Workplace | 1 | 2008 | 873 | 0.050 |
Why?
|
| Sex Factors | 2 | 2017 | 10622 | 0.050 |
Why?
|
| Endophenotypes | 1 | 2023 | 258 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2017 | 8531 | 0.050 |
Why?
|
| Risk | 2 | 2011 | 9606 | 0.050 |
Why?
|
| Guidelines as Topic | 2 | 2017 | 1396 | 0.050 |
Why?
|
| Infant Care | 1 | 2002 | 182 | 0.050 |
Why?
|
| Emergency Medicine | 2 | 2002 | 1220 | 0.050 |
Why?
|
| Drug Discovery | 1 | 2009 | 1068 | 0.050 |
Why?
|
| Tears | 1 | 2003 | 254 | 0.050 |
Why?
|
| Pulmonary Wedge Pressure | 1 | 2022 | 277 | 0.050 |
Why?
|
| Administration, Inhalation | 1 | 2024 | 1154 | 0.050 |
Why?
|
| Hospitals, Urban | 1 | 2003 | 495 | 0.040 |
Why?
|
| Intestinal Perforation | 1 | 2002 | 254 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2012 | 3468 | 0.040 |
Why?
|
| Informed Consent | 1 | 2007 | 1010 | 0.040 |
Why?
|
| Self Report | 1 | 2012 | 3773 | 0.040 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 59548 | 0.040 |
Why?
|
| Demography | 1 | 2005 | 1641 | 0.040 |
Why?
|
| Calibration | 1 | 2003 | 817 | 0.040 |
Why?
|
| Evidence-Based Medicine | 1 | 2012 | 3700 | 0.040 |
Why?
|
| Program Development | 1 | 2006 | 1298 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 1998 | 5519 | 0.040 |
Why?
|
| Communication Barriers | 1 | 2003 | 419 | 0.040 |
Why?
|
| Quality Control | 1 | 2003 | 835 | 0.040 |
Why?
|
| Fibrinogen | 1 | 2003 | 892 | 0.040 |
Why?
|
| C-Reactive Protein | 1 | 1991 | 3851 | 0.040 |
Why?
|
| Urinary Tract Infections | 2 | 2009 | 804 | 0.040 |
Why?
|
| Antipsychotic Agents | 1 | 2013 | 3078 | 0.040 |
Why?
|
| Quality of Life | 3 | 2021 | 13485 | 0.040 |
Why?
|
| Public Health Practice | 1 | 2002 | 220 | 0.040 |
Why?
|
| Disease Progression | 1 | 2016 | 13646 | 0.040 |
Why?
|
| Fragile X Mental Retardation Protein | 1 | 2020 | 115 | 0.040 |
Why?
|
| Periodicals as Topic | 1 | 2010 | 1465 | 0.040 |
Why?
|
| Georgia | 1 | 2019 | 186 | 0.040 |
Why?
|
| Appendectomy | 1 | 2002 | 444 | 0.040 |
Why?
|
| Remission, Spontaneous | 1 | 1999 | 384 | 0.040 |
Why?
|
| Genome-Wide Association Study | 2 | 2024 | 12790 | 0.040 |
Why?
|
| Education, Medical, Continuing | 1 | 2004 | 829 | 0.040 |
Why?
|
| Population Dynamics | 1 | 2020 | 314 | 0.040 |
Why?
|
| Dilatation | 1 | 2000 | 311 | 0.040 |
Why?
|
| Substance-Related Disorders | 2 | 2017 | 4422 | 0.040 |
Why?
|
| Patient Satisfaction | 2 | 2003 | 3488 | 0.040 |
Why?
|
| Breast Feeding | 2 | 2004 | 1362 | 0.040 |
Why?
|
| Hyperbilirubinemia | 1 | 1998 | 74 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2000 | 398 | 0.040 |
Why?
|
| Vasodilator Agents | 1 | 2022 | 988 | 0.040 |
Why?
|
| Peer Review, Research | 1 | 2021 | 343 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2012 | 2441 | 0.040 |
Why?
|
| Ankle Injuries | 1 | 2001 | 339 | 0.040 |
Why?
|
| Patient Care Management | 1 | 2000 | 302 | 0.040 |
Why?
|
| Liability, Legal | 1 | 1998 | 209 | 0.030 |
Why?
|
| Hypertension | 1 | 2017 | 8615 | 0.030 |
Why?
|
| Cold Temperature | 1 | 2020 | 793 | 0.030 |
Why?
|
| Mental Recall | 1 | 2003 | 1218 | 0.030 |
Why?
|
| Research | 2 | 2002 | 1977 | 0.030 |
Why?
|
| Health Surveys | 1 | 2006 | 4056 | 0.030 |
Why?
|
| Health Behavior | 1 | 2008 | 2650 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 2004 | 1278 | 0.030 |
Why?
|
| Pilot Projects | 1 | 2009 | 8732 | 0.030 |
Why?
|
| North America | 1 | 2019 | 1287 | 0.030 |
Why?
|
| Thrombocytopenia | 1 | 2003 | 1172 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2002 | 856 | 0.030 |
Why?
|
| National Heart, Lung, and Blood Institute (U.S.) | 1 | 2016 | 325 | 0.030 |
Why?
|
| Stomach | 1 | 1999 | 701 | 0.030 |
Why?
|
| Patient Advocacy | 1 | 1997 | 362 | 0.030 |
Why?
|
| Managed Care Programs | 1 | 2000 | 939 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2019 | 2275 | 0.030 |
Why?
|
| Socioeconomic Factors | 2 | 2017 | 7848 | 0.030 |
Why?
|
| Opioid-Related Disorders | 1 | 2009 | 2188 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2021 | 18063 | 0.030 |
Why?
|
| Qualitative Research | 2 | 2019 | 3139 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2024 | 16036 | 0.030 |
Why?
|
| Pain | 1 | 2009 | 5101 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2020 | 1441 | 0.030 |
Why?
|
| Action Potentials | 1 | 2021 | 1835 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2000 | 1198 | 0.030 |
Why?
|
| Analgesics, Opioid | 1 | 2009 | 3837 | 0.030 |
Why?
|
| Health Care Surveys | 2 | 2011 | 2428 | 0.030 |
Why?
|
| Pulmonary Artery | 1 | 2021 | 1944 | 0.030 |
Why?
|
| Decision Making | 1 | 2007 | 3951 | 0.030 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2017 | 773 | 0.030 |
Why?
|
| Radiography | 2 | 2001 | 6975 | 0.020 |
Why?
|
| Freedom | 1 | 2012 | 69 | 0.020 |
Why?
|
| Acute-Phase Reaction | 1 | 1991 | 91 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2022 | 4186 | 0.020 |
Why?
|
| Mesocricetus | 1 | 1991 | 256 | 0.020 |
Why?
|
| India | 1 | 2018 | 2334 | 0.020 |
Why?
|
| Interviews as Topic | 1 | 1999 | 2741 | 0.020 |
Why?
|
| Social Class | 1 | 2000 | 2007 | 0.020 |
Why?
|
| Embryonic and Fetal Development | 1 | 1991 | 420 | 0.020 |
Why?
|
| Certification | 1 | 2014 | 420 | 0.020 |
Why?
|
| DNA, Neoplasm | 1 | 2016 | 1741 | 0.020 |
Why?
|
| Family | 1 | 2021 | 3210 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 2744 | 0.020 |
Why?
|
| Information Management | 1 | 2010 | 100 | 0.020 |
Why?
|
| Prognosis | 2 | 2021 | 29963 | 0.020 |
Why?
|
| Referral and Consultation | 2 | 2018 | 3618 | 0.020 |
Why?
|
| Diffusion of Innovation | 1 | 2014 | 724 | 0.020 |
Why?
|
| Sepsis | 1 | 2003 | 2605 | 0.020 |
Why?
|
| Antiviral Agents | 1 | 2021 | 3070 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2000 | 5311 | 0.020 |
Why?
|
| Genotype | 1 | 2023 | 13035 | 0.020 |
Why?
|
| Curriculum | 1 | 2002 | 3786 | 0.020 |
Why?
|
| Europe | 1 | 2015 | 3432 | 0.020 |
Why?
|
| Climate | 1 | 2009 | 146 | 0.020 |
Why?
|
| Population Density | 1 | 2008 | 193 | 0.020 |
Why?
|
| Patents as Topic | 1 | 2009 | 111 | 0.020 |
Why?
|
| Cricetinae | 1 | 1991 | 2415 | 0.020 |
Why?
|
| Genome | 1 | 2016 | 1752 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2019 | 3610 | 0.020 |
Why?
|
| Neoplasms | 2 | 2016 | 22350 | 0.020 |
Why?
|
| Random Allocation | 1 | 2012 | 2394 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2000 | 5537 | 0.020 |
Why?
|
| Child Welfare | 1 | 2011 | 522 | 0.020 |
Why?
|
| Otitis Media | 1 | 2009 | 287 | 0.020 |
Why?
|
| Hospitals, Community | 1 | 2009 | 363 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2019 | 10092 | 0.020 |
Why?
|
| Cities | 1 | 2009 | 542 | 0.020 |
Why?
|
| Canada | 1 | 2011 | 2127 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 2010 | 772 | 0.020 |
Why?
|
| Caregivers | 1 | 1998 | 2302 | 0.020 |
Why?
|
| Bacillus anthracis | 1 | 2005 | 120 | 0.020 |
Why?
|
| Spores, Bacterial | 1 | 2005 | 114 | 0.010 |
Why?
|
| Health Literacy | 1 | 2010 | 466 | 0.010 |
Why?
|
| Craniocerebral Trauma | 1 | 2009 | 493 | 0.010 |
Why?
|
| Physicians, Primary Care | 1 | 2011 | 623 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2009 | 2276 | 0.010 |
Why?
|
| Needs Assessment | 1 | 2010 | 1141 | 0.010 |
Why?
|
| Brain | 2 | 2022 | 27163 | 0.010 |
Why?
|
| Probability | 1 | 2009 | 2476 | 0.010 |
Why?
|
| Lipopolysaccharides | 1 | 1991 | 2217 | 0.010 |
Why?
|
| Public Sector | 1 | 2005 | 266 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 9532 | 0.010 |
Why?
|
| Automation | 1 | 2005 | 587 | 0.010 |
Why?
|
| Ethics, Medical | 1 | 2007 | 785 | 0.010 |
Why?
|
| Private Sector | 1 | 2005 | 397 | 0.010 |
Why?
|
| Arthritis | 3 | 1951 | 684 | 0.010 |
Why?
|
| Phototherapy | 1 | 2004 | 368 | 0.010 |
Why?
|
| Motivation | 1 | 2010 | 2021 | 0.010 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2003 | 352 | 0.010 |
Why?
|
| Diatrizoate Meglumine | 1 | 1999 | 80 | 0.010 |
Why?
|
| Medicaid | 1 | 2013 | 2836 | 0.010 |
Why?
|
| Fibula | 1 | 2001 | 270 | 0.010 |
Why?
|
| Milk, Human | 1 | 2003 | 490 | 0.010 |
Why?
|
| Maternal Health Services | 1 | 2003 | 472 | 0.010 |
Why?
|
| Laparotomy | 1 | 1999 | 459 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 1991 | 12793 | 0.010 |
Why?
|
| Cytokines | 1 | 1991 | 7446 | 0.010 |
Why?
|
| Home Care Services | 1 | 2002 | 659 | 0.010 |
Why?
|
| Liver | 1 | 1991 | 7578 | 0.010 |
Why?
|
| Gene Expression Regulation | 1 | 1991 | 11923 | 0.010 |
Why?
|
| Cognition | 1 | 2010 | 7059 | 0.010 |
Why?
|
| Iodine Isotopes | 1 | 1951 | 79 | 0.010 |
Why?
|
| Mutation | 1 | 2016 | 30211 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2008 | 22254 | 0.010 |
Why?
|
| Salicylates | 1 | 1950 | 127 | 0.010 |
Why?
|
| Pregnancy | 1 | 1991 | 30238 | 0.010 |
Why?
|
| Fractures, Bone | 1 | 2001 | 2062 | 0.010 |
Why?
|
| Iodine | 1 | 1951 | 285 | 0.000 |
Why?
|
| Clinical Competence | 1 | 2004 | 4859 | 0.000 |
Why?
|
| Immunization, Passive | 1 | 1949 | 619 | 0.000 |
Why?
|
| Contrast Media | 1 | 1999 | 5329 | 0.000 |
Why?
|
| Arthritis, Rheumatoid | 2 | 1951 | 3778 | 0.000 |
Why?
|
| Rheumatic Diseases | 1 | 1951 | 659 | 0.000 |
Why?
|
| Diarrhea | 1 | 1951 | 1319 | 0.000 |
Why?
|
| Estrogens | 1 | 1950 | 1536 | 0.000 |
Why?
|
| Neuralgia | 1 | 1949 | 619 | 0.000 |
Why?
|
| Blood Transfusion | 1 | 1949 | 1308 | 0.000 |
Why?
|
| Prostate | 1 | 1950 | 1761 | 0.000 |
Why?
|
| Animals | 1 | 1991 | 168965 | 0.000 |
Why?
|